Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Shipley

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Oncology (Williston Park, N.Y.)|June 13, 2003
Phase I. Trial of irinotecan and temozolomide in patients with solid tumorsSuzanne F Jones, Victor G Gian, F Anthony Greco, et al.
Molecular Pharmacology|February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activityP J Davies, S A Berry, G L Shipley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancerDavid R Spigel, Howard A Burris, F Anthony Greco, et al.
American Journal of Obstetrics and Gynecology|February 3, 2009
Enhanced estrogen-induced proliferation in obese rat endometriumQian Zhang, Qi Shen, Joseph Celestino, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2012
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancerDavid R Spigel, F Anthony Greco, David M Waterhouse, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 18, 2007
Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signalingP Hanifi-Moghaddam, B Boers-Sijmons, A H A Klaassens, et al.
Clinical Chemistry|April 11, 2013
The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR ExperimentsJim F Huggett, Carole A Foy, Vladimir Benes, et al.
The Oncologist|August 18, 2019
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE TrialDavid R Spigel, Dianna L Shipley, David M Waterhouse, et al.
Clinical Chemistry|April 24, 2025
MIQE 2.0: Revision of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments GuidelinesStephen A Bustin, Jan M Ruijter, Maurice J B van den Hoff, et al.
The Oncologist|September 23, 2017
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER TrialAndrew H Ko, Patrick B Murphy, James D Peyton, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Oncology (Williston Park, N.Y.)|June 13, 2003
Phase I. Trial of irinotecan and temozolomide in patients with solid tumorsSuzanne F Jones, Victor G Gian, F Anthony Greco, et al.
Molecular Pharmacology|February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activityP J Davies, S A Berry, G L Shipley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancerDavid R Spigel, Howard A Burris, F Anthony Greco, et al.
American Journal of Obstetrics and Gynecology|February 3, 2009
Enhanced estrogen-induced proliferation in obese rat endometriumQian Zhang, Qi Shen, Joseph Celestino, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2012
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancerDavid R Spigel, F Anthony Greco, David M Waterhouse, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 18, 2007
Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signalingP Hanifi-Moghaddam, B Boers-Sijmons, A H A Klaassens, et al.
Clinical Chemistry|April 11, 2013
The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR ExperimentsJim F Huggett, Carole A Foy, Vladimir Benes, et al.
The Oncologist|August 18, 2019
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE TrialDavid R Spigel, Dianna L Shipley, David M Waterhouse, et al.
Clinical Chemistry|April 24, 2025
MIQE 2.0: Revision of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments GuidelinesStephen A Bustin, Jan M Ruijter, Maurice J B van den Hoff, et al.
The Oncologist|September 23, 2017
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER TrialAndrew H Ko, Patrick B Murphy, James D Peyton, et al.
Pageof 11